{"disease":{"id":"monkey-pox","name":"monkey pox"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07093489","title":"Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":11990,"lead_sponsor_name":"International Vaccine Institute","has_results":false},{"nct_id":"NCT05922735","title":"Seroprevalence of Monkeypox Infection Among People Living With HIV and PrEP Users","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT05745987","title":"Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT05965427","title":"Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV","phase":"","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"NEAT ID Foundation","has_results":true},{"nct_id":"NCT02977715","title":"JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Centers for Disease Control and Prevention","has_results":false},{"nct_id":"NCT06840860","title":"Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT07199569","title":"Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":970,"lead_sponsor_name":"Bavarian Nordic","has_results":false},{"nct_id":"NCT06839989","title":"An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT05559099","title":"Tecovirimat for Treatment of Monkeypox Virus","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":597,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT07267390","title":"Investigating MPXV Viral Clearance in Mpox Cases and Secondary Attack Rate in Contacts","phase":"","overall_status":"RECRUITING","enrollment_count":550,"lead_sponsor_name":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","has_results":false},{"nct_id":"NCT05734508","title":"Assessment of Safety Profile of MVA-BN Vaccine in the PALM-007 Study in DRC","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT05543577","title":"Assessing the Preparedness and Knowledge of Pharmacists in the Current Monkeypox Outbreak","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Beni-Suef University","has_results":false},{"nct_id":"NCT06549530","title":"Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":460,"lead_sponsor_name":"Bavarian Nordic","has_results":false},{"nct_id":"NCT05740982","title":"A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT06353737","title":"Looking for Asymptomatic Mpox in a Population at High Risk","phase":"","overall_status":"RECRUITING","enrollment_count":450,"lead_sponsor_name":"Unity Health Toronto","has_results":false},{"nct_id":"NCT05846243","title":"Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":334,"lead_sponsor_name":"Federal Budgetary Research Institution State Research Center of Virology and Biotechnology \"Vector\"","has_results":false},{"nct_id":"NCT05627713","title":"Clinical and Biological Aspects of the MONKEYPOX Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT06721585","title":"Tecovirimat for Treatment of Monkeypox Virus - Study Extension Providing Standard of Care Only","phase":"","overall_status":"COMPLETED","enrollment_count":328,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06579885","title":"Ocular Complications of Mpox in the Democratic Republic Congo","phase":"","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT05058898","title":"A One Health Study of Monkeypox Human Infection","phase":"","overall_status":"UNKNOWN","enrollment_count":280,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT05512949","title":"Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":229,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT05651581","title":"Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT07253675","title":"Evaluate the Safety and Immunogenicity of the MVA-SIBP Vaccine in the Democratic Republic of the Congo","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Shanghai Institute Of Biological Products","has_results":false},{"nct_id":"NCT06442501","title":"Observational Mondkeypox Pregnancy Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Robert Colebunders","has_results":false},{"nct_id":"NCT06984705","title":"Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part3)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":144,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT07055867","title":"Epidemiological and Clinical Characteristics of Mpox Outbreak in Equateur, the DR Congo (Part1)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":122,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT07067723","title":"Epidemiological and Clinical Characteristics of Human Mpox Outbreak in Equateur Province in the Democratic Republic of Congo (Part2)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":122,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT05698082","title":"FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"xiaoliang Huang","has_results":false},{"nct_id":"NCT05534165","title":"Tecovirimat in Non-hospitalized Patients With Monkeypox","phase":"PHASE3","overall_status":"SUSPENDED","enrollment_count":120,"lead_sponsor_name":"Marina Klein","has_results":false},{"nct_id":"NCT03745131","title":"Cohort Study of Healthcare Workers Receiving Imvanex®","phase":"","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Public Health England","has_results":false},{"nct_id":"NCT06771479","title":"A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Shanghai Institute Of Biological Products","has_results":false},{"nct_id":"NCT06045923","title":"Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Centers for Disease Control and Prevention","has_results":false},{"nct_id":"NCT05988203","title":"A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"BioNTech SE","has_results":false},{"nct_id":"NCT07342829","title":"Prospective Follow-up After MVA-BN Booster Vaccination","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":95,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT05976100","title":"Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Federal Budgetary Research Institution State Research Center of Virology and Biotechnology \"Vector\"","has_results":false},{"nct_id":"NCT05476744","title":"Viral Clearance and Epidemiological Characteristics in Patients With Monkeypox","phase":"","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","has_results":false},{"nct_id":"NCT07377175","title":"Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":76,"lead_sponsor_name":"China National Biotec Group Company Limited","has_results":false},{"nct_id":"NCT05762523","title":"Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Federal Budgetary Research Institution State Research Center of Virology and Biotechnology \"Vector\"","has_results":false},{"nct_id":"NCT07085611","title":"Neutralizing Power of Serum Antibodies - 2","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Centre Hospitalier Régional d'Orléans","has_results":false},{"nct_id":"NCT05443867","title":"Monkeypox ASymptomatic Shedding: Evaluation by Self-Sampling MPX-ASSESS","phase":"","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Institute of Tropical Medicine, Belgium","has_results":false},{"nct_id":"NCT05947786","title":"Mpox Paediatric and Adolescent Clinical Study","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"PENTA Foundation","has_results":false},{"nct_id":"NCT05567939","title":"Clinical, Virological, Immunological, Psychosocial and Epidemiological Consequences of Human Monkeypox Virus (ProMPX)","phase":"","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Public Health Service of Amsterdam","has_results":false},{"nct_id":"NCT02080767","title":"Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"U.S. Army Medical Research and Development Command","has_results":false}],"total":43},"guidelines":[],"source":"Drug Landscape verified database"}